Claris Lifesciences has received an Abbreviated New Drug Application (ANDA) approval for Levofloxacin Injection; having strength of 25mg/ ml in 20 ml vials in the United States of America (US). Levofloxacin Injection is an anti-infective drug administered on adults suffering from infection such as Pneumonia, Acute Bacterial Sinusitis or Complicated Urinary Tract Infection, etc. The intravenous route of administration is considered advantageous to the patient.
Claris is also one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.
| Company Name | CMP |
|---|---|
| Redington | 227.50 |
| Adani Enterprises | 2228.00 |
| Amrapali Industries | 17.36 |
| Rashi Peripheral | 474.40 |
| PDS | 294.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: